Parathyroid Hormone: all 33 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy AdultsCompletedNCT05137730Phase 1Results posted
- Safety and Efficacy Study of rhPTH(1-84) in Subjects With HypoparathyroidismTerminatedNCT03364738Phase 3Results posted
- A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)CompletedNCT03324880Phase 4Results posted
- Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult SubjectsCompletedNCT03150108Phase 1Results posted
- A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in HypoparathyroidismCompletedNCT02910466Phase 4Results posted
- A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in HungaryCompletedNCT01455181Phase 3Results posted
- A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)CompletedNCT01297309Phase 3Results posted
- Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)CompletedNCT01268098Phase 3Results posted
- HEXT (Hypo EXTended): Effect of PTH on Skeleton in HypoparathyroidismCompletedNCT01199614Phase 3Results posted
- Use of NPSP558 in the Treatment of HypoparathyroidismCompletedNCT00732615Phase 3Results posted
- The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)TerminatedNCT00713258Phase 4Results posted
- PTH & Ibandronate Combination Study (PICS)CompletedNCT00683163Phase 2/3Results posted
- Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)CompletedNCT00479037Phase 4Results posted
- Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated DonorTerminatedNCT00393380Phase 2Results posted
- 7 Day Continuous Parathyroid Hormone IV InfusionCompletedNCT00377312Early Phase 1Results posted
- Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)CompletedNCT00365456Phase 3Results posted
- Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid UseCompletedNCT00221299Phase 4Results posted
- A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic HypoparathyroidismWithdrawnNCT03878953Phase 3
- A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo PenCompletedNCT02478879Phase 1
- Treatment With PTH After Sternotomy in Cardiac Surgery PatientsCompletedNCT01466829Phase 3
- One Week Comparison Study of PTH and PTHrP InfusionsWithdrawnNCT01333267Phase 1
- ADD-ON Study to Existing Hypoparathyroidism StudiesStatus unknownNCT00856401Phase 3
- Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of LifeCompletedNCT00730210Phase 2
- STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)CompletedNCT00583518Phase 4
- Calcium Supplementation in Postmenopausal WomenCompletedNCT00172172Phase 3
- Open Label Extension Study of PREOSCompletedNCT00172133Phase 3
- Open Label ExtensionCompletedNCT00172120Phase 3
- A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal OsteoporosisCompletedNCT00172107Phase 2
- TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal OsteoporosisCompletedNCT00172081Phase 3
- Treatment of Psoriasis With Parathyroid HormoneCompletedNCT00007306Phase 1/2
- Parathyroid Hormone (PTH) With Alendronate for OsteoporosisCompletedNCT00005006Phase 2
- Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced OsteoporosisCompletedNCT00004993Phase 2
- Effects of Parathyroid Hormone in Men With OsteoporosisCompletedNCT00000427Phase 3